American Oriental Signs Up with US CRO for Clinical Trials

American Oriental Bioengineering has struck a deal with Palm Beach Clinical Research Organization (PBCRO) of the US to use PBCRO to oversee American clinical trials of AOBO-developed pharmaceuticals. American Oriental did not disclose which of its products it plans to enter into the process of FDA registration. AOBO makes both prescription and OTC products, along with nutraceuticals. More details.... Stock Symbol: (NYSE: AOB)